2cn0 Citations

Mapping the fluorophilicity of a hydrophobic pocket: synthesis and biological evaluation of tricyclic thrombin inhibitors directing fluorinated alkyl groups into the p pocket.

Abstract

In the completion of our fluorine scan of tricyclic inhibitors to map the fluorophilicity/fluorophobicity of the thrombin active site, a series of 11 new ligands featuring alkyl, alkenyl, and fluoroalkyl groups was prepared to explore fluorine effects on binding into the hydrophobic proximal (P) pocket, lined by Tyr 60A and Trp 60D, His 57, and Leu 99. The synthesis of the tricyclic scaffolds was based on the 1,3-dipolar cycloaddition of azomethine ylides, derived from L-proline and 4-bromobenzaldehyde, with N-(4-fluorobenzyl)maleimide. Introduction of alkyl, alkenyl, and partially fluorinated alkyl residues was achieved upon substitution of a sulfonyl group by mixed Mg/Zn organometallics followed by oxidation/deoxyfluorination, as well as oxidation/reduction/deoxyfluorination sequences. In contrast, the incorporation of perfluoroalkyl groups required a stereoselective nucleophilic addition reaction at the "upper" carbonyl group of the tricycles, thereby yielding scaffolds with an additional OH, F, or OMe group, respectively. All newly prepared inhibitors showed potent biological activity, with inhibitory constants (K(i) values) in the range of 0.008-0.163 microM. The X-ray crystal structure of a protein-ligand complex revealed the exact positioning of a difluoromethyl substituent in the tight P pocket. Fluorophilic characteristics are attributed to this hydrophobic pocket, although the potency of the inhibitors was found to be modulated by steric rather than electronic factors.

Articles - 2cn0 mentioned but not cited (3)

  1. Protein-protein docking benchmark version 3.0. Hwang H, Pierce B, Mintseris J, Janin J, Weng Z. Proteins 73 705-709 (2008)
  2. Significant enhancement of docking sensitivity using implicit ligand sampling. Xu M, Lill MA. J Chem Inf Model 51 693-706 (2011)
  3. Evaluating the therapeutic role of selected active compounds in Plumula Nelumbinis on pulmonary hypertension via network pharmacology and experimental analysis. Xiao X, Luo F, Fu M, Jiang Y, Liu S, Liu B. Front Pharmacol 13 977921 (2022)


Reviews citing this publication (2)

  1. Fluorine in pharmaceuticals: looking beyond intuition. Müller K, Faeh C, Diederich F. Science 317 1881-1886 (2007)
  2. Predicting and tuning physicochemical properties in lead optimization: amine basicities. Morgenthaler M, Schweizer E, Hoffmann-Röder A, Benini F, Martin RE, Jaeschke G, Wagner B, Fischer H, Bendels S, Zimmerli D, Schneider J, Diederich F, Kansy M, Müller K. ChemMedChem 2 1100-1115 (2007)

Articles citing this publication (5)

  1. Introduction of fluorine and fluorine-containing functional groups. Liang T, Neumann CN, Ritter T. Angew Chem Int Ed Engl 52 8214-8264 (2013)
  2. Halogenated ligands and their interactions with amino acids: implications for structure-activity and structure-toxicity relationships. Kortagere S, Ekins S, Welsh WJ. J Mol Graph Model 27 170-177 (2008)
  3. Catalytic asymmetric radical aminoperfluoroalkylation and aminodifluoromethylation of alkenes to versatile enantioenriched-fluoroalkyl amines. Lin JS, Wang FL, Dong XY, He WW, Yuan Y, Chen S, Liu XY. Nat Commun 8 14841 (2017)
  4. Synthesis and elastase-inhibiting activity of 2-pyridinyl-isothiazol-3(2H)-one 1,1-dioxides. Eilfeld A, González Tanarro CM, Frizler M, Sieler J, Schulze B, Gütschow M. Bioorg Med Chem 16 8127-8135 (2008)
  5. Parallel imaging of coagulation pathway proteases activated protein C, thrombin, and factor Xa in human plasma. Modrzycka S, Kołt S, Polderdijk SGI, Adams TE, Potoczek S, Huntington JA, Kasperkiewicz P, Drąg M. Chem Sci 13 6813-6829 (2022)